Coronavirus situation under control in Delhi, not terrible, says Kejriwal
Maruti reports 54% YoY decline in sales in June; sells less than 40% of pre-coronavirus level
Government Bans 59 Chinese Apps Including Tik-Tok, Shareit, UC Browser, and WeChat
PM Modi to address the nation at 4 pm: What to expect
Maharashtra Extends Lockdown Till July 31 Day After Urging Caution
Coronavirus Vaccine Update
Swarms Of Desert Locusts Reach Delhi Outskirts After Gurugram
Delhi fighting difficult battle against COVID-19, will emerge victorious: Kejriwal
2-Week Lockdown In Guwahati From Monday; Minister Says "Shop By Sunday"
YouTube likely to come up with TikTok-like short video platform
Rs 2,000 crore from PM CARES Fund to be spent on 50,0000 ventilators for COVID-19 patients
Baba Ramdev's Patanjali launches India's 'first Ayurvedic' medicine for coronavirus, Coronil
Coronavirus: Glenmark conducts Fabiflu trial on 1,000 patients; to compete with Gilead's Remdesivir
Jio's golden touch makes Reliance Industries share rise 108% in 3 months
Coronavirus vaccine: When will it be ready? Moderna, AstraZeneca offer answers
Chennai lockdown starts today: Check what is allowed, not allowed
Coronavirus vaccine: Singapore scientists discover 5 antibodies that can combat COVID-19
India-China tension: Indian Army releases list of 20 martyrs; wreath ceremony begins in Leh
Tamil Nadu announces 'maximised restricted lockdown' from June 19 in Chennai, 3 other districts
Maruti Suzuki's Alto becomes India's top-selling car for 16th year in a row

Latest Posts

Coronavirus vaccine update: After Moderna, CanSino Biologics claims positive results in early trials

latest news update

The preliminary findings of the test for the coronavirus vaccine being developed by CanSino Biologics have shown favourable results, a study showed. The potential COVID-19 vaccine appeared safe and triggered an immune response in healthy adults in the early trials, the study published in the health journal The Lancet said. The early trials showed that the experimental vaccine, Ad5-nCoV, may help train the human body to resist infection by the new SARS-CoV-2 virus. The study includes 108 participants aged between 18 and 60 years and with no history of coronavirus infection. The phase 1 trials were conducted in Wuhan, Hubei province.

It comes days after biotechnology company Moderna had said that the preliminary findings of its test for coronavirus vaccine development have shown favourable results. The experimental vaccine appears to be safe and able to trigger an immune response against the infection, Moderna had said. There are more than 100 coronavirus vaccines being currently developed globally.

Meanwhile, Union Health Minister Harsh Varshan on Sunday said that at least four of the candidate coronavirus vaccines are soon expected to enter the clinical trial stage. "There are over 100 candidate vaccines  which are at different levels of development. The World Health Organisation (WHO) is coordinating the efforts. India is also actively contributing in it," Vardhan said in a social media interaction with Bharatiya Janata Party (BJP) leader G V L Narasimha Rao.

"As far as I know, four of our fourteen  vaccines will soon be in the clinical trial stage, within 4 to 5 months. All the 14 are right now at the pre-clinical trial stage," he added.


Alert Message

Please Wait...

Share the Opinion Poll with your Friends At


Share the Survey with your
Friends At